Drug
Olanzapine
Olanzapine: highest development phase Post-Market, developed by Dr. Reddy's, Eli Lilly, LEO Pharma and others. 5 trial records tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Dr. Reddy's, Eli Lilly, LEO Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| Olanzapine Hydrochloride NCT00485823 | Post-Market | Schizophrenic Disorders |
| OLANZAPINE | Approved | |
| WELTRUZA | Approved | |
| Olanzapine NCT00113594 | Phase 3 | Schizophrenia |
| Olanzapine NCT01503398 | Phase 1 | Fasting |
Latest
Follow Olanzapine on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.